Skip to content
DeepViews

Azenta, Inc. (AZTA) — Analysis Summary

Azenta, Inc. (AZTA) has a market cap of $1.65B with year-over-year revenue growth of -9.5%. Net margin stands at -9.4%. The stock trades at a P/E ratio of -13.4.

Key Takeaways

  • Revenue changed -9.5% year-over-year
  • Net margin of -9.4%
  • P/E ratio of -13.4

Compared to other companies in the SPECIAL INDUSTRY MACHINERY, NEC sector, AZTA posted revenue growth of -9.5% and trades at a P/E of -13.4.

[XNAS]

Azenta, Inc. (AZTA)

$37.77

PREVIOUS CLOSE 2026-10-12 · MARKET DATA POLYGON · FINANCIALS SEC EDGAR

Market Cap
$1652.45M
Enterprise Value
$1326.66M
P/E Ratio
-13.4
Div Yield
1.06%
EV/EBITDA
-11.0
Company Profile
About
About Azenta, Inc.

Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.

Sector

SPECIAL INDUSTRY MACHINERY, NEC

Employees

2,900

Headquarters

BURLINGTON, MA

Exchange

XNAS

Website
Source: Polygon.io
Score
Competitive Moat
Competitive Moat
32
No Moat

Systematic competitive advantage assessment based on 4yr data

This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.

Market Signals
Valuation
Earnings
Insider Activity
Insider Filing Activity

First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.

Loading SEC insider filing activity...
Superinvestors
Financial Health
Financial Health

Capital Structure

Total Equity$1510.13M
Total Debt$0.00M
Debt-to-Equity0.00
Cash & Equivalents$189.65M

Cash Flow

Operating Cash Flow$37.98M
Free Cash Flow$9.88M
FCF Margin1.61%
P/FCF Ratio167.24
Source: Polygon.io · SEC EDGAR
Dividends
Dividends

Annual Dividend/Share

$0.40

Dividend Yield

1.06%

Quarterly
Last Ex-Date: 2021-12-02

Dividend History

2021-12-02
CD$0.1000
2021-09-02
CD$0.1000
2021-06-03
CD$0.1000
2021-03-04
CD$0.1000
Source: Polygon.io
Recent News
Recent News

Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.